Financial Synergies Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$1.24K | – | 307 |
|
|
2024
Q1 | $1.24K | Sell |
9
-3
| -25% | -$414 | ﹤0.01% | 375 |
|
|
2023
Q4 | $1.43K | Buy |
+12
| New | +$1.43K | ﹤0.01% | 283 |
|
|
2023
Q1 | – | Sell |
-12
| Closed | -$1.43K | – | 506 |
|
|
2022
Q4 | $1.43K | Hold |
12
| – | – | ﹤0.01% | 283 |
|
|
2022
Q3 | $1.28K | Buy |
+12
| New | +$1.28K | ﹤0.01% | 268 |
|